ICON PLC

NASDAQ: ICLR (ICON plc)

Last update: 4 days ago, 2:57PM

163.57

-1.97 (-1.19%)

Previous Close 165.53
Open 165.45
Volume 852,687
Avg. Volume (3M) 1,022,037
Market Cap 12,619,727,872
Price / Earnings (TTM) 251.64
Price / Earnings (Forward) 17.06
Price / Sales 1.68
Price / Book 1.48
52 Weeks Range
66.57 (-59%) — 203.91 (24%)
Earnings Date 21 Oct 2026
Profit Margin 9.82%
Operating Margin (TTM) 12.83%
Diluted EPS (TTM) 9.71
Quarterly Revenue Growth (YOY) -4.80%
Quarterly Earnings Growth (YOY) 24.50%
Total Debt/Equity (MRQ) 37.12%
Current Ratio (MRQ) 1.29
Operating Cash Flow (TTM) 1.16 B
Levered Free Cash Flow (TTM) 901.28 M
Return on Assets (TTM) 4.35%
Return on Equity (TTM) 8.30%

Market Trend

Short Term Medium Term
Industry Diagnostics & Research (US) Mixed Bullish
Diagnostics & Research (Global) Mixed Bullish
Stock ICON plc Mixed Bearish

AIStockmoo Score

0.8
Analyst Consensus NA
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages 2.5
Technical Oscillators 2.0
Average 0.83

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
ICLR 13 B - 251.64 1.48
IDXX 45 B - 41.78 28.34
NTRA 39 B - - 21.62
ILMN 31 B - 37.95 10.93
GH 22 B - - 55.67
MEDP 16 B - 34.60 37.09

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Sector Healthcare
Industry Diagnostics & Research
Investment Style Mid Value
% Held by Insiders 0.63%
% Held by Institutions 92.70%

No data within this time range.

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria